LSV Asset Management’s Integra LifeSciences IART Stock Holding History

LSV Asset Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.91M	Hold	217,700	–	–	0.01%	529
2026 Q1	$2.05M	Sell	217,700 -3,600	-2%	-$39.5K	﹤0.01%	565
2025 Q4	$2.75M	Hold	221,300	–	–	0.01%	544
2025 Q3	$3.17M	Sell	221,300 -16,600	-7%	-$227K	0.01%	524
2025 Q2	$2.92M	Hold	237,900	–	–	0.01%	513
2025 Q1	$5.23M	Hold	237,900	–	–	0.01%	471
2024 Q4	$5.4M	Buy	237,900 +29,300	+14%	+$640K	0.01%	472
2024 Q3	$3.79M	Buy	+208,600	New	+$4.84M	0.01%	530

Other funds holding IART

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

LSV Asset Management's IART Position: Q2 2026 in Review

LSV Asset Management held its Integra LifeSciences (IART) position steady in Q2 2026 at 217,700 shares worth $3.91M. The position accounts for 0.01% of the portfolio, ranked #529.

LSV Asset Management first reported a position in IART in Q3 2024 and has held it in 8 quarters since. The position peaked at $5.4M in Q4 2024. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

LSV Asset Management held 217,700 shares of Integra LifeSciences worth $3.91M as of Q2 2026.
LSV Asset Management left its Integra LifeSciences share count unchanged in Q2 2026.
Integra LifeSciences made up 0.01% of LSV Asset Management's portfolio in Q2 2026, its #529 holding.
LSV Asset Management first reported a position in Integra LifeSciences in Q3 2024 and has held it in 8 quarters since.
LSV Asset Management's Integra LifeSciences position peaked at $5.4M in Q4 2024.
212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on LSV Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.